Antidiabetic activity of benzopyrone analogues in nicotinamide-streptozotocin induced type 2 diabetes in rats

Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Nayak, Yogendra ^a   Hillemane, Venkatachalam ^b   Daroji, Vijay Kumar ^a,c   Ayashree, B S J ^a   Unnikrishnan, M K ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

^b KASTURBA MEDICAL COLLEGE   (India)

^c Department of Pharmaceutical Chemistry Manipal College of Pharmaceutical Sciences Manipal University ^*  (India)

Author keywords

[No Author keywords available]

Indexed keywords

2 (4 ETHYLPHENYL) 3 HYDROXY 4H CHROMEN 4 ONE; 2 [4 (DIMETHYLAMINO)PHENYL] 3 HYDROXY 4H CHROMEN 4 ONE; 2 [4 (DIMETHYLAMINO)PHENYL] 3,7 DIHYDROXY 4H CHROMEN 4 ONE; 3 HYDROXY 6 METHYL 2 (4 METHYLPHENYL) 4H CHROMEN 4 ONE; ANTIDIABETIC AGENT; BENZOPYRONE DERIVATIVE; GLIBENCLAMIDE; INSULIN; NICOTINAMIDE; QUERCETIN; STREPTOZOCIN; UNCLASSIFIED DRUG; ADVANCED GLYCATION END PRODUCT; BIOLOGICAL MARKER; COUMARIN; COUMARIN DERIVATIVE; CREATININE; GLUCOSE BLOOD LEVEL; GLYCOGEN; LIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CALCULATION; CONTROLLED STUDY; DIET RESTRICTION; DRUG SYNTHESIS; EXPERIMENTAL DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; LIPID BLOOD LEVEL; LIVER HOMOGENATE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PANCREAS; RAT; STANDARD; WISTAR RAT; ANIMAL; BLOOD; CHEMISTRY; COMPLICATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; LIVER; METABOLISM;

RATTUS; RATTUS NORVEGICUS;

ANIMALS; BIOMARKERS; BLOOD GLUCOSE; COUMARINS; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; FASTING; GLUCOSE TOLERANCE TEST; GLYCOGEN; GLYCOSYLATION END PRODUCTS, ADVANCED; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; LIPIDS; LIVER; MALE; NIACINAMIDE; OXIDATIVE STRESS; PANCREAS; RATS, WISTAR; STREPTOZOCIN;

EID: 84918828617     PISSN: 23566140     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/854267     Document Type: Article

References (22)

1. V. Poitout and R. P. Robertson, "Glucolipotoxicity: fuel excess and β-cell dysfunction," Endocrine Reviews, vol. 29, no. 3, pp. 351-366, 2008.
2. M. Brownlee, "The pathobiology of diabetic complications: a unifying mechanism," Diabetes, vol. 54, no. 6, pp. 1615-1625, 2005.
3. M. Brownlee, "Biochemistry and molecular cell biology of diabetic complications," Nature, vol. 414, no. 6865, pp. 813-820, 2001.
4. N. A. Calcutt, M. E. Cooper, T. S. Kern, and A. M. Schmidt, "Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials," Nature Reviews Drug Discovery, vol. 8, no. 5, pp. 417-429, 2009.
5. Y. Nayak, B. S. Jayashree, and M. K. Unnikrishnan, "Benzo-pyran- 4-one is an ideal pharmacophore for lead optimization in antidiabetic drug discovery," Research Journal of Pharmacy and Technology, vol. 5, no. 8, pp. 1025-1033, 2012.
6. L. H. Cazarolli, L. Zanatta, E. H. Alberton et al., "Flavonoids: cellular and molecular mechanism of action in glucose homeostasis," Mini-Reviews inMedicinal Chemistry, vol. 8, no. 10, pp. 1032-1038, 2008.
7. V. P.Veerapur, K. R. Prabhakar, M. R. Kandadi, K. K. Srinivasan, and M. K. Unnikrishnan, "Antidiabetic effect of Dodonaea viscosa aerial parts in high fat diet and low dose streptozotocin-induced type 2 diabetic rats: a mechanistic approach," Pharmaceutical Biology, vol. 48, no. 10, pp. 1137-1148, 2010.
8. V. P. Veerapur, K. R. Prabhakar, B. S.Thippeswamy, P. Bansal, K. K. Srinivasan, and M. K. Unnikrishnan, "Antidiabetic effect of Dodonaea viscosa (L). Lacq. aerial parts in high fructose-fed insulin resistant rats: a mechanism based study," Indian Journal of Experimental Biology, vol. 48, no. 8, pp. 800-810, 2010.
9. B. H. Havsteen, "The biochemistry and medical significance of the flavonoids," Pharmacology & Therapeutics, vol. 96, no. 2-3, pp. 67-202, 2002.
10. B. S. Jayashree, F. A. Noor, N. Yogendra, and D. Vijay Kumar, "Synthesis of substituted 3-hydroxy flavones for antioxidant and antimicrobial activity," Pharmacologyonline, vol. 3, pp. 586-595, 2008.
11. Y. Nayak, B. Jayashree, and M. Unnikrishnan, "Antioxidant, DNA protection and antiglycation activity of benzopyrone-4- one analogues," in Dubai International Pharmaceuticals and Technologies Conference and Exhibition (DUPHAT '12), March 2012, Poster Code F-26.
12. I. S. R. Punitha, K. Rajendran, and A. Shirwaikar, "Alcoholic stem extract of Coscinium fenestratum regulates carbohydrate metabolism and improves antioxidant status in streptozotocin-nicotinamide induced diabetic rats," Evidence-Based Complementary and Alternative Medicine, vol. 2, no. 3, pp. 375-381, 2005.
13. Y. Nayak, H. Venkatachalam, D. Vijay Kumar et al., "Synthesis of benzopyran-4-one analogues and their antidiabetic activity in insulin resistant rats," in Proceedings of the BioPharm Asia Convention, Singapore, March 2011.
14. A. A. Rossini, R. M. Williams, M. C. Appel, and A. A. Like, "Sex differences in the multiple-dose streptozotocin model of diabetes," Endocrinology, vol. 103, no. 4, pp. 1518-1520, 1978.
15. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, "Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.," Clinical Chemistry, vol. 18, no. 6, pp. 499-502, 1972.
16. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, "Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man," Diabetologia, vol. 28, no. 7, pp. 412-419, 1985.
17. A. Akinmokun, P. L. Selby, K. Ramaiya, and K. G. M. M. Alberti, "The short insulin tolerance test for determination of insulin sensitivity: a comparison with the euglycaemic clamp," Diabetic Medicine, vol. 9, no. 5, pp. 432-437, 1992.
18. K. Yanagisawa, Z. Makita, K. Shiroshita et al., "Specific fluorescence assay for advanced glycation end products in blood and urine of diabetic patients," Metabolism: Clinical and Experimental, vol. 47, no. 11, pp. 1348-1353, 1998.
19. J. vn der Vies, "Two methods for the determination of glycogen in liver," TheBiochemical Journal, vol. 57,no. 3, pp.410-416, 1954.
20. O. Coskun, M. Kanter, A. Korkmaz, and S. Oter, "Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and β-cell damage in rat pancreas," Pharmacological Research, vol. 51, no. 2, pp. 117-123, 2005.
21. R. B. Goldberg, "Lipid disorders in diabetes," Diabetes Care, vol. 4, no. 5, pp. 561-572, 1981.
22. W. Arozal, K. Watanabe, P. T. Veeraveedu et al., "Effects of angiotensin receptor blocker on oxidative stress and cardiorenal function in streptozotocin-induced diabetic rats," Biological and Pharmaceutical Bulletin, vol. 32, no. 8, pp. 1411-1416, 2009.